Pleuropulmonary Paragonimiasis
Paragonimiasis pleuro pulmonar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.
Show authors biography
Paragonimiasis is a foodborne anthropozoonoses, caused by Paragonimus genus being P. Westwermanii, the one that infects humans. Human infection occurs after the intake of freshwater crustaceans poorly cooked, infected with metacercariae. The severity and progression of symptoms depend on the stage and the number of parasites present. The stage of lung infection is characterized by cough, hemoptysis, chest pain, weight loss and radiographic findings. Since respiratory symptoms and radiological findings nonspecific pulmonary TB is the main differential diagnosis to consider. The diagnosis is based on the demonstration of Paragonimus parasitological means, in some cases as extra pulmonary paragonimiasis or other circumstances when bacteriological methods fail is necessary serological studies. Praziquantel is currently considered the treatment of choice.
Article visits 134 | PDF visits 659
Downloads
- Aka N, Adoubryn K, Rondelaud D, Dreyfuss G. Human Paragonimiasis In Africa. Ann Afr Med 2008; 7: 153-162.
- Odermatt P, Habe A, Manichanh A, et al. Paragonimiasis and its intermediate hosts in a transmission focus in Lao People’s Democratic Republic. Acta Tropica 2007; 103: 108–115.
- Madariaga MG, Ruma t, Theis JH, . Autochthonous Human Paragonimiasis in North America. Wild and Envir Med 2007; 18: 203-205.
- Devi R, et al, Pleuropulmonary paragonimiasis due to Paragonimus heterotremus: molecular diagnosis, prevalence of infection and clinicoradiological features in an endemic area of northeastern India. Trans R Soc Trop Med Hyg 2007; 101:786-92.
- Meehan AM, Virk A, Swanson K, Poeschla EM. Severe Pleuropulmonary Paragonimiasis 8 Years after Emigration from a Region of Endemicity. CID 2002;35: 87-90.
- Nkouawa A, et al, Paragonimiasis in Cameroon: molecular identification, serodiagnosis and clinical manifestations. Trans R Soc Trop Med Hyg 2009; 103: 255-61. 7.
- Nakamura-Uchiyama F, Mukae H, Nawa Y. Paragonimiasis: a Japanese perspective. Clin Chest Med 2002; 23: 409-420.
- Liu Q, Wei F, Liu W, Yang S, Zhang X, Paragonimiasis: an important food-borne zoonosis in China. Tren in Parasitol 2008; 24: 318-22.
- Vélez IV, Ortega JE, Velásquez LE.Paragonimiasis: a view from Columbia. Clin Chest Med 2002; 23: 421-31.
- Uruburu M, Granada M, Velásquez LE. Distribución parcial de Paragonimus (Digenea: Troglotrematidae) en Antioquia, por presencia de metacercarias en cangrejos dulciacuícolas. Biomédica 2008; 28: 562-8.
- Toscano C, Hai YS, Nunn P, Mott KE. Paragonimiasis and Tuberculosis diagnostic confusion: A review of the literature. Trop Dis Bull 1995; 92: 1-27.
- Vélez ID, Ortega J, Hurtado MI, Salazar AL, Robledo SM, Jimenez JN, et al. Epidemiology of paragonimiasis in Colombia. Trans R Soc Trop Med Hyg 2000; 94(6): 661-3.
- Pearson RD, Guerrant RL. Praziquantel: a major advance in antihelminthic therapy. Ann Intern Med 1983; 99: 195-8
- Drugs for parasitic infections. Med Lett Drugs Ther. 1982; 24(601): 5-12.
- Praziquantel-a new antiparasitic drug. Med Lett Drugs Ther 1982; 24(624): 108-9.
- Li R. Clinical observation of treating 44 cases of paragonimiasis (Paragonimus westermani) with praziquantel [in Chinese]. Zhonghua Nei Ke Za Zh 1982; 21(1): 37-8.
- Monson MH, Koenig JW, Sachs R. Successful treatment with praziquantel of six patients infected with the African lung fluke, Paragonimus uterobilaterialis. Am J Trop Med Hyg 1983; 32: 371-5.
- Parasitic Disease Drug Service. Informational material: bithional NF, internal use. Atlanta: Center for Disease Control, 1977.
- Cabrera BD, Fevidal PM. Studies on Paragonimus and paragonimiasis in the Philippines. 3. Prevalence and treat-ment of human paragonimiasis with bithionol in Jaro, Leyte, Philippines. Southeast Asian J Trop Med Public Health 1974; 5: 39-45.
- Kim JS. Treatment of Paragonimus westermani infections with bithionol. Am J Trop Med Hyg 1970; 19: 940-2.
- Coleman DL, Barry M. Relapse of Paragonimus westermani lung infection after bithionol therapy. Am J Trop Med Hyg 1982; 31: 71-4 35.
- Yokogawa M, Iwasaki M, Shigeyasu M, Hirose H, Okura T, Tsuji M. Chemotherapy of paragonimiasis with bithionol. V. Studies on the minimum effective dose and changes in abnormal x-ray shadows in the chest after treatment. Am J Trop Med Hyg 1963;12: 859-69.
- Singh TN, Singh HR, Devi KhS, Singh NB, Singh YI. Pulmonary paragonimiasis. Indian J Chest Dis Allied Sci. 2004 Jul-Sep;46(3):225-7.
- Vanijanota S, Bunnaj D, Harinasuta T. Praziquantel and niclofolan in the treatment of pulmonary paragonimiasis [abstract no. 296]. In: Program and abstracts of the 10th International Congress on Tropical Medicine and Malaria, Manila, Philippines, 1980.
- Rim HJ, Chang YS. Chemotherapeutic effect of nicolofolan and praziquantel in the treatment of paragonimiasis. Korean University Medical Jornal 1980;12:1134
- Nwokolo C, Volkmer KJ. Single dose therapy of paragonimiasis with menichlopholan. Am J Trop Med Hyg 1977;26: 688-92.
- Gao J, Liu Y, Wang X, Hu P. Triclabendazole in the treatment of Paragonimiasis skrjabini. Chin Med J (Engl) 2003; 116(11): 1683- 6.
- Calvopiña M, Guderian RH, Paredes W, Chico M, Cooper PJ. Treatment of human pulmonary paragonimiasis with triclabendazole: clinical tolerance and drug efficacy. Trans R Soc Trop Med Hyg 1998; 92(5): 566-9.
- Benjapong W, Naeypatimanond S, Benjapong K, Thumaruksa C, Ruttarasarn S, Jaroonvesama N. Studies on paragonimiasis: treatment with mebendazole, emetine with mebendazole and praziquantel. Southeast Asian J Trop Med Public Health 1984; 15(3): 354-9.